PKC wants to design and release what we call our Standard Dextran Portfolio. The strategic work lying behind such design is currently ongoing. PKC wants to offer a Standard Dextran Portfolio which fits the best into our customers needs. The Standard Dextran Portfolio will contain the classical monographed dextrans in combination with other more specialty dextrans.
PKC is currently producing Dextran in technical quality and will soon also be able to produce dextrans in pharmaceutical quality. Thanks to our highly skilled experts and state-of-the art modern equipment, our various dextrans displays a very narrow molecular weight distribution.